Active Ingredients
lauryl alcohol polye-ther-9 5%
Private Backya-rd Relaxation Gel
FDA Label NDC 84372-057
12 label sections · Submitted to the FDA by Shenzhen Zhumeng Times Technology Co., Ltd. · Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Shenzhen Zhumeng Times Technology Co., Ltd. for the product Private Backya-rd Relaxation Gel (NDC 84372-057). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients, purpose, uses, contraindications, precautions, warnings, and instructions, dosage and administration, do not use, when using section, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Purpose
Loose anal muscles
Uses
Apply around the anus and wait 5 minutes
Contraindications, Precautions, Warnings, And Instructions
Prohibit ingestion by mouth.
Do not put into eyes or ears.
No contact with wounds.
Dosage And Administration
For external use only.
Do Not Use
Skin irritation occurs, wash with water, discontinue use
If symptoms do not improve, seek medical attention immediately
When Using Section
Skin irritation occurs, wash with water, discontinue use
If symptoms do not improve, seek medical attention immediately。
Allow 5 minutes for the product to take effect
Inactive Ingredients
Water,PEG-7 coco-nut glycerin,PEG-4o hydrogenated pi-edmont oil,ethylene glycol phenyl ether,aminomethylpropanol,propionic acid/C10-30,alkyl acr-ylic polymer,carbomer,ethyl he-xyl glycerol,oat kernel extract,menthol oil,glycerin,hop oil,di-pentene
Stop Use
Wound breaks
Keep Out Of Reach Of Children.
If sxralowed, get medical help or contact a Poison Conirol Cenler ngiht away.
Recent Major Changes
Package
Principal Display Panel
Label (123)
* Please review the disclaimer below.
